ReviewClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Integrins as key regulators in tumor perineural invasion: mechanisms and clinical implications.
Review in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perineural invasion (PNI) serves as an important prognostic indicator in various solid tumors, closely associated with tumor recurrence and reduced survival rates. At present, the molecular mechanisms of initiating PNI have been extensively studied but still lack targets employed for efficient diagnosis and treatment clinically. The integrins' family is major cell adhesion receptors linking the cytoskeleton to the extracellular matrix (ECM) and mediating bidirectional signaling involved in tumor development. Recently, emerging evidence has emphasized the crucial role of integrins in PNI. To comprehensively understand its potential regulatory mechanisms and application prospects, this review summarizes the latest research on integrins affecting PNI, covering their molecular characteristics, oncogenic mechanisms, and clinical significance. In addition, we also point out the current challenges and propose innovative strategies to promote the advancement of tumor diagnosis, prognosis prediction, and therapeutic strategies.
Indexed as
Identifiers
41504864What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.